Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · IEX Real-Time Price · USD
8.26
-0.12 (-1.43%)
At close: May 17, 2024, 4:00 PM
8.67
+0.41 (4.96%)
After-hours: May 17, 2024, 4:29 PM EDT
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $261.41 million as of May 17, 2024. Its market cap has increased by 140.49% in one year.
Market Cap
261.41M
Enterprise Value
209.45M
1-Year Change
140.49%
Ranking
Category
Stock Price
$8.26
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $261.41M, a decrease of -46.45%. That is a compound annual growth rate of -19.73%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 269.70M | -1.43% |
May 16, 2024 | 273.60M | -0.62% |
May 15, 2024 | 275.30M | 0.95% |
May 14, 2024 | 272.70M | -8.21% |
May 13, 2024 | 297.10M | -1.75% |
May 10, 2024 | 302.40M | -5.41% |
May 9, 2024 | 319.70M | 5.27% |
May 8, 2024 | 303.70M | -1.20% |
May 7, 2024 | 307.40M | -4.45% |
May 6, 2024 | 321.70M | -8.56% |
May 3, 2024 | 351.80M | 2.06% |
May 2, 2024 | 344.70M | 1.92% |
May 1, 2024 | 338.20M | -10.79% |
Apr 30, 2024 | 379.10M | 4.87% |
Apr 29, 2024 | 361.50M | 3.70% |
Apr 26, 2024 | 348.60M | 3.97% |
Apr 25, 2024 | 335.30M | 2.98% |
Apr 24, 2024 | 325.60M | 0.80% |
Apr 23, 2024 | 323.00M | 1.96% |
Apr 22, 2024 | 316.80M | 0.19% |
Apr 19, 2024 | 316.20M | -0.38% |
Apr 18, 2024 | 317.40M | 1.12% |
Apr 17, 2024 | 313.90M | -1.23% |
Apr 16, 2024 | 317.80M | -2.40% |
Apr 15, 2024 | 325.60M | 3.96% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Rani Therapeutics Holdings | 263.19M |
Sanara MedTech | 263.07M |
Cybin | 262.63M |
Zura Bio | 262.10M |
Monte Rosa Therapeutics | 261.65M |
Auna S.A. | 260.40M |
ESSA Pharma | 258.19M |
Enanta Pharmaceuticals | 257.97M |